Targeting the JMJD6/TGF-β axis in prostate cancer by immunotherapy: A potential treatment based on RNA splicing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the JMJD6/TGF-β axis in prostate cancer by immunotherapy: A potential treatment based on RNA splicing

Published:2023-02 Issue: Volume:171 Page:111018
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Ni Yuanli,Xu Jing,Tong Dali^ORCID

Funder

Chongqing Municipal Health and Family Planning Commission

Chongqing Science and Technology Commission

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Prostate cancer treatment – China's perspective;Liu;Cancer Lett,2022

2. Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment;Tong;J Immunother Cancer,2022

3. Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways;Zhou;J Exp Clin Cancer Res,2018

4. Bifunctional enzyme JMJD6 contributes to multiple disease pathogenesis: new twist on the old story;Vangimalla;Biomolecules,2017

5. The role of JMJD6/U2AF65/AR-V7 axis in castration-resistant prostate cancer progression;Tong;Cancer Cell Int,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases;International Journal of Molecular Sciences;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP